Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Evaluation of Serum Estradiol Levels According to Body Mass Index Categories in Premenopausal Patients With Hormone Receptor-Positive Breast Cancer Receiving Aromatase Inhibitors and Pharmacologic Ovarian Suppression

NCT07833501 is registered in ClinicalTrials.gov with D'Or Institute for Research and Education as lead sponsor.

NCT NCT07833501
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07833501 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Evaluation of Serum Estradiol Levels According to Body Mass Index Categories in Premenopausal Patients With Hormone Receptor-Positive Breast Cancer Receiving Aromatase Inhibitors and Pharmacologic Ovarian Suppression
Lead sponsor
D'Or Institute for Research and Education
Phase
Observational
Overall status
Not yet recruiting
Start date
September 3, 2026
Completion date
May 30, 2027
Enrollment
172 (estimated)
Sites
Not reported

Conditions

As the registry lists them; a condition with its own page is linked.

hormone receptor-positive breast cancer